IL6 and cancer: However, high heterogeneity was found for IL-6, which might be attributed to region, cancer type, treatment method, sample source, and detection method.<h4>Conclusion</h4>The peripheral level of IL-8 may be used as a prognostic marker to identify patients with inferior response to ICIs.